ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

ClinicalTrials.gov ID: NCT06615557

Public ClinicalTrials.gov record NCT06615557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)

Study identification

NCT ID
NCT06615557
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
VistaGen Therapeutics, Inc.
Industry
Enrollment
236 participants

Conditions and interventions

Interventions

  • Fasedienol Nasal Spray Drug
  • Placebo Nasal Spray Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2024
Primary completion
Mar 31, 2026
Completion
Mar 31, 2027
Last update posted
Apr 23, 2026

2024 – 2027

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Vistagen Clinical Site Phoenix Arizona 85012 Recruiting
Vistagen Clinical Site Little Rock Arkansas 72211 Active, not recruiting
Vistagen Clinical Site Bellflower California 90706 Recruiting
Vistagen Clinical Site Oceanside California 92056 Recruiting
Vistagen Clinical Site Orange California 92868 Recruiting
Vistagen Clinical Site Redlands California 92374 Active, not recruiting
Vistagen Clinical Site Torrance California 90504 Recruiting
Vistagen Clinical Site Denver Colorado 80209 Recruiting
Vistagen Clinical Site Tampa Florida 33629 Recruiting
Vistagen Clinical Site Decatur Georgia 30030 Active, not recruiting
Vistagen Clinical Site Chicago Illinois 60640 Active, not recruiting
Vistagen Clinical Site Naperville Illinois 60563 Recruiting
Vistagen Clinical Site Boston Massachusetts 02131 Recruiting
Vistagen Clinical Site Bloomfield Township Michigan 48302 Terminated
Vistagen Clinical Site Flowood Mississippi 39232 Recruiting
Vistagen Clinical Site Las Vegas Nevada 89119 Active, not recruiting
Vistagen Clinical Site Las Vegas Nevada 89121 Terminated
Vistagen Clinical Site Albuquerque New Mexico 87109 Recruiting
Vistagen Clinical Site New York New York 10128 Recruiting
Vistagen Clinical Site Cincinnati Ohio 45229 Terminated
Vistagen Clinical Site Austin Texas 78737 Recruiting
Vistagen Clinical Site Austin Texas 78759 Recruiting
Vistagen Clinical Site Dallas Texas 75251 Recruiting
Vistagen Clinical Site Houston Texas 77055 Recruiting
Vistagen Clinical Site San Antonio Texas 78229 Recruiting
Vistagen Clinical Site Everett Washington 98201 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06615557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06615557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →